AfroCentric Investment Corp Ltd 2016 IR
The report details AfroCentric Group's financial and operational performance for the fiscal year ended June 30, 2016, highlighting its transition into an integrated healthcare company. Key achievements include securing the South African Police Service Medical Scheme (Polmed) contract and completing the acquisitions of Pharmacy Direct, Curasana, and a stake in Activo Health. The company maintained its Level 2 B-BBEE status and advanced its technology capabilities through investments in the Fusion IT platform and FICO's Insurance Fraud Manager software.
Company: AfroCentric Investment Corp Ltd
Sector: Financials
Country: South Africa
Year: 2016
Type: IR
Pages: 136
AfroCentric Investment Corp Ltd
The report details AfroCentric Group's financial and operational performance for the fiscal year ended June 30, 2016, highlighting its transition into an integrated healthcare company. Key achievements include securing the South African Police Service Medical Scheme (Polmed) contract and completing the acquisitions of Pharmacy Direct, Curasana, and a stake in Activo Health. The company maintained its Level 2 B-BBEE status and advanced its technology capabilities through investments in the Fusion IT platform and FICO's Insurance Fraud Manager software.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jul 1, 2015 - Jun 30, 2016
Fiscal Year
2016
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees